Biocare Medical is proud to announce the launch of RISH™

A new, innovative, chromogenic ISH technology: reducing protocol length from two days to approximately 2.5 hours. In a simplified protocol we have removed the need for RNase free solutions & labware, the overnight hybridization and harsh stringent wash conditions. The proprietary DNA probe technology ensures high specificity and accuracy for the target.

The result is clear: virtually no background, a clean chromogenic signal. You can visualize the target under brightfield microscopy, along with the tissue morphology on a single slide. This 5-step procedure is as simple as IHC – bringing what was once considered a tedious technology to every lab.

We will be launching with a small subset of probes initially, these RISH™ Probes are designed for the diagnosis and classification of hematopoietic and lymphoid neoplasms: EBER, Kappa and Lambda Light Chains.

About Biocare Medical

Biocare Medical LLC is an innovator in developing and supplying world class automated immunohistochemistry instrumentation, and the full range of reagents for IHC lab testing. Biocare is the market leader in simultaneous Multiplex IHC and antibody development which solves difficult clinical problems and accelerates turnaround time.

The company’s customers include clinical histology laboratories, pharmaceutical companies, CROs, and biotechnology companies as well as academic, government, military, and other non-profit laboratories. Biocare Medical offers an expanding portfolio of integrated products to address the rapidly growing cancer and infectious disease diagnostic and research markets using tissue immunostaining and in situ hybridization methods. Biocare medical is headquartered and has manufacturing facilities in Concord, Calif., and has a global distribution network.

Please contact your local Biocare Medical Sales Representative for more information.

Posted By: Biocare Medical On: 20-May-2010